Compare FTRE & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | AHCO |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2023 | 2017 |
| Metric | FTRE | AHCO |
|---|---|---|
| Price | $9.82 | $10.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $15.39 | $13.25 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,723,400,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | $3.01 | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $3.97 | $7.11 |
| 52 Week High | $18.67 | $11.17 |
| Indicator | FTRE | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 56.90 |
| Support Level | $9.05 | $8.67 |
| Resistance Level | $11.22 | $10.66 |
| Average True Range (ATR) | 0.64 | 0.45 |
| MACD | 0.22 | 0.08 |
| Stochastic Oscillator | 55.28 | 77.22 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.